GSK-933776 is a humanized antibody expressed in CHO, targeting Amyloid Beta/Abeta. GSK-933776 has huIgG1 heavy chain and hukappa light chain, with a predicted molecular weight (MW) of 145.34 kDa. The isotype control for GSK-933776 can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
